Description: Compliance with 21 CFR Part 11 and EU Annexure guidelines is essential for pharmaceutical companies operating in regulated global markets. These standards focus on data integrity, electronic records, electronic signatures, validation systems, and quality assurance processes to ensure transparency, traceability, and product safety. TajMedico follows strict compliance practices to meet international regulatory expectations and maintain the highest standards in pharmaceutical manufacturing. 21 CFR Part 11, issued by the U.S. FDA, governs the use of electronic records and signatures in pharmaceutical operations. It ensures that digital data used in production, testing, and quality control is secure, accurate, and properly controlled. EU Annexure guidelines support Good Manufacturing Practices by defining standards for validation, documentation, computerized systems, and cleanroom operations within European markets. TajMedico implements advanced digital systems, controlled access procedures, audit trails, and validated software platforms to support regulatory compliance. Regular internal audits, staff training, and documented quality processes help maintain readiness for inspections and international business requirements. Compliance with these regulations improves operational efficiency, reduces risk, and builds trust with customers, regulators, and healthcare partners. It also strengthens product quality and supports global market expansion. Through continuous improvement and commitment to excellence, TajMedico ensures alignment with international standards, reinforcing its reputation as a reliable pharmaceutical manufacturing partner worldwide.
Dimensions: 1621 x 1080
File Type: jpeg
File Size: 167 KB
